Global Vitamin K Antagonists (VKA) Market Research Report 2020

Global Vitamin K Antagonists (VKA) Market Research Report 2020

Table of Contents
1 Vitamin K Antagonists (VKA) Market Overview
1.1 Product Overview and Scope of Vitamin K Antagonists (VKA)
1.2 Vitamin K Antagonists (VKA) Segment by Type
1.2.1 Global Vitamin K Antagonists (VKA) Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Oral Vitamin K Antagonists
1.2.3 Injection Vitamin K Antagonists
1.3 Vitamin K Antagonists (VKA) Segment by Application
1.3.1 Vitamin K Antagonists (VKA) Sales Comparison by Application: 2020 VS 2026
1.3.2 VTE
1.3.3 ACS/MI
1.3.4 AF
1.3.5 Others
1.4 Global Vitamin K Antagonists (VKA) Market Size Estimates and Forecasts
1.4.1 Global Vitamin K Antagonists (VKA) Revenue 2015-2026
1.4.2 Global Vitamin K Antagonists (VKA) Sales 2015-2026
1.4.3 Vitamin K Antagonists (VKA) Market Size by Region: 2020 Versus 2026
2 Global Vitamin K Antagonists (VKA) Market Competition by Manufacturers
2.1 Global Vitamin K Antagonists (VKA) Sales Market Share by Manufacturers (2015-2020)
2.2 Global Vitamin K Antagonists (VKA) Revenue Share by Manufacturers (2015-2020)
2.3 Global Vitamin K Antagonists (VKA) Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Vitamin K Antagonists (VKA) Manufacturing Sites, Area Served, Product Type
2.5 Vitamin K Antagonists (VKA) Market Competitive Situation and Trends
2.5.1 Vitamin K Antagonists (VKA) Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Vitamin K Antagonists (VKA) Players (Opinion Leaders)
3 Vitamin K Antagonists (VKA) Retrospective Market Scenario by Region
3.1 Global Vitamin K Antagonists (VKA) Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Vitamin K Antagonists (VKA) Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Vitamin K Antagonists (VKA) Market Facts & Figures by Country
3.3.1 North America Vitamin K Antagonists (VKA) Sales by Country
3.3.2 North America Vitamin K Antagonists (VKA) Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Vitamin K Antagonists (VKA) Market Facts & Figures by Country
3.4.1 Europe Vitamin K Antagonists (VKA) Sales by Country
3.4.2 Europe Vitamin K Antagonists (VKA) Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Vitamin K Antagonists (VKA) Market Facts & Figures by Region
3.5.1 Asia Pacific Vitamin K Antagonists (VKA) Sales by Region
3.5.2 Asia Pacific Vitamin K Antagonists (VKA) Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Vitamin K Antagonists (VKA) Market Facts & Figures by Country
3.6.1 Latin America Vitamin K Antagonists (VKA) Sales by Country
3.6.2 Latin America Vitamin K Antagonists (VKA) Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Vitamin K Antagonists (VKA) Market Facts & Figures by Country
3.7.1 Middle East and Africa Vitamin K Antagonists (VKA) Sales by Country
3.7.2 Middle East and Africa Vitamin K Antagonists (VKA) Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Vitamin K Antagonists (VKA) Historic Market Analysis by Type
4.1 Global Vitamin K Antagonists (VKA) Sales Market Share by Type (2015-2020)
4.2 Global Vitamin K Antagonists (VKA) Revenue Market Share by Type (2015-2020)
4.3 Global Vitamin K Antagonists (VKA) Price Market Share by Type (2015-2020)
4.4 Global Vitamin K Antagonists (VKA) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Vitamin K Antagonists (VKA) Historic Market Analysis by Application
5.1 Global Vitamin K Antagonists (VKA) Sales Market Share by Application (2015-2020)
5.2 Global Vitamin K Antagonists (VKA) Revenue Market Share by Application (2015-2020)
5.3 Global Vitamin K Antagonists (VKA) Price by Application (2015-2020)
6 Company Profiles and Key Figures in Vitamin K Antagonists (VKA) Business
6.1 Sanofi
6.1.1 Corporation Information
6.1.2 Sanofi Description, Business Overview and Total Revenue
6.1.3 Sanofi Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Sanofi Products Offered
6.1.5 Sanofi Recent Development
6.2 Bristol-Myers Squibb
6.2.1 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Production Sites and Area Served
6.2.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
6.2.3 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Bristol-Myers Squibb Products Offered
6.2.5 Bristol-Myers Squibb Recent Development
6.3 Bayer
6.3.1 Bayer Vitamin K Antagonists (VKA) Production Sites and Area Served
6.3.2 Bayer Description, Business Overview and Total Revenue
6.3.3 Bayer Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Bayer Products Offered
6.3.5 Bayer Recent Development
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Vitamin K Antagonists (VKA) Production Sites and Area Served
6.4.2 Johnson & Johnson Description, Business Overview and Total Revenue
6.4.3 Johnson & Johnson Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Johnson & Johnson Products Offered
6.4.5 Johnson & Johnson Recent Development
6.5 Genentech (Roche)
6.5.1 Genentech (Roche) Vitamin K Antagonists (VKA) Production Sites and Area Served
6.5.2 Genentech (Roche) Description, Business Overview and Total Revenue
6.5.3 Genentech (Roche) Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Genentech (Roche) Products Offered
6.5.5 Genentech (Roche) Recent Development
6.6 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Vitamin K Antagonists (VKA) Production Sites and Area Served
6.6.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
6.6.3 Boehringer Ingelheim Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Boehringer Ingelheim Products Offered
6.6.5 Boehringer Ingelheim Recent Development
6.7 Lilly
6.6.1 Lilly Vitamin K Antagonists (VKA) Production Sites and Area Served
6.6.2 Lilly Description, Business Overview and Total Revenue
6.6.3 Lilly Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Lilly Products Offered
6.7.5 Lilly Recent Development
6.8 Daiichi Sankyo
6.8.1 Daiichi Sankyo Vitamin K Antagonists (VKA) Production Sites and Area Served
6.8.2 Daiichi Sankyo Description, Business Overview and Total Revenue
6.8.3 Daiichi Sankyo Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Daiichi Sankyo Products Offered
6.8.5 Daiichi Sankyo Recent Development
6.9 Otsuka
6.9.1 Otsuka Vitamin K Antagonists (VKA) Production Sites and Area Served
6.9.2 Otsuka Description, Business Overview and Total Revenue
6.9.3 Otsuka Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Otsuka Products Offered
6.9.5 Otsuka Recent Development
6.10 AstraZeneca
6.10.1 AstraZeneca Vitamin K Antagonists (VKA) Production Sites and Area Served
6.10.2 AstraZeneca Description, Business Overview and Total Revenue
6.10.3 AstraZeneca Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2015-2020)
6.10.4 AstraZeneca Products Offered
6.10.5 AstraZeneca Recent Development
6.11 Pfizer
6.11.1 Pfizer Vitamin K Antagonists (VKA) Production Sites and Area Served
6.11.2 Pfizer Vitamin K Antagonists (VKA) Description, Business Overview and Total Revenue
6.11.3 Pfizer Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Pfizer Products Offered
6.11.5 Pfizer Recent Development
6.12 Aspen
6.12.1 Aspen Vitamin K Antagonists (VKA) Production Sites and Area Served
6.12.2 Aspen Vitamin K Antagonists (VKA) Description, Business Overview and Total Revenue
6.12.3 Aspen Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Aspen Products Offered
6.12.5 Aspen Recent Development
6.13 The Medicines Company
6.13.1 The Medicines Company Vitamin K Antagonists (VKA) Production Sites and Area Served
6.13.2 The Medicines Company Vitamin K Antagonists (VKA) Description, Business Overview and Total Revenue
6.13.3 The Medicines Company Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2015-2020)
6.13.4 The Medicines Company Products Offered
6.13.5 The Medicines Company Recent Development
7 Vitamin K Antagonists (VKA) Manufacturing Cost Analysis
7.1 Vitamin K Antagonists (VKA) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Vitamin K Antagonists (VKA)
7.4 Vitamin K Antagonists (VKA) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Vitamin K Antagonists (VKA) Distributors List
8.3 Vitamin K Antagonists (VKA) Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Vitamin K Antagonists (VKA) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Vitamin K Antagonists (VKA) by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Vitamin K Antagonists (VKA) by Type (2021-2026)
10.2 Vitamin K Antagonists (VKA) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Vitamin K Antagonists (VKA) by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Vitamin K Antagonists (VKA) by Application (2021-2026)
10.3 Vitamin K Antagonists (VKA) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Vitamin K Antagonists (VKA) by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Vitamin K Antagonists (VKA) by Region (2021-2026)
10.4 North America Vitamin K Antagonists (VKA) Estimates and Projections (2021-2026)
10.5 Europe Vitamin K Antagonists (VKA) Estimates and Projections (2021-2026)
10.6 Asia Pacific Vitamin K Antagonists (VKA) Estimates and Projections (2021-2026)
10.7 Latin America Vitamin K Antagonists (VKA) Estimates and Projections (2021-2026)
10.8 Middle East and Africa Vitamin K Antagonists (VKA) Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Vitamin K Antagonists (VKA) Sales (K MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Vitamin K Antagonists (VKA) Sales (K MT) Comparison by Application: 2020 VS 2026
Table 3. Global Vitamin K Antagonists (VKA) Market Size by Type (K MT) (US$ Million) (2020 VS 2026)
Table 4. Global Key Vitamin K Antagonists (VKA) Manufacturers Covered in This Study
Table 5. Global Vitamin K Antagonists (VKA) Sales (K MT) by Manufacturers (2015-2020)
Table 6. Global Vitamin K Antagonists (VKA) Sales Share by Manufacturers (2015-2020)
Table 7. Global Vitamin K Antagonists (VKA) Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Vitamin K Antagonists (VKA) Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Vitamin K Antagonists (VKA) Average Price (USD/MT) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Vitamin K Antagonists (VKA) Sales Sites and Area Served
Table 11. Manufacturers Vitamin K Antagonists (VKA) Product Types
Table 12. Global Vitamin K Antagonists (VKA) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Vitamin K Antagonists (VKA) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vitamin K Antagonists (VKA) as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Vitamin K Antagonists (VKA) Players
Table 16. Global Vitamin K Antagonists (VKA) Sales (K MT) by Region (2015-2020)
Table 17. Global Vitamin K Antagonists (VKA) Sales Market Share by Region (2015-2020)
Table 18. Global Vitamin K Antagonists (VKA) Revenue (Million US$) by Region (2015-2020)
Table 19. Global Vitamin K Antagonists (VKA) Revenue Market Share by Region (2015-2020)
Table 20. North America Vitamin K Antagonists (VKA) Sales by Country (2015-2020) (K MT)
Table 21. North America Vitamin K Antagonists (VKA) Sales Market Share by Country (2015-2020)
Table 22. North America Vitamin K Antagonists (VKA) Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Vitamin K Antagonists (VKA) Revenue Market Share by Country (2015-2020)
Table 24. Europe Vitamin K Antagonists (VKA) Sales by Country (2015-2020) (K MT)
Table 25. Europe Vitamin K Antagonists (VKA) Sales Market Share by Country (2015-2020)
Table 26. Europe Vitamin K Antagonists (VKA) Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Vitamin K Antagonists (VKA) Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Vitamin K Antagonists (VKA) Sales by Region (2015-2020) (K MT)
Table 29. Asia Pacific Vitamin K Antagonists (VKA) Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Vitamin K Antagonists (VKA) Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Vitamin K Antagonists (VKA) Revenue Market Share by Region (2015-2020)
Table 32. Latin America Vitamin K Antagonists (VKA) Sales by Country (2015-2020) (K MT)
Table 33. Latin America Vitamin K Antagonists (VKA) Sales Market Share by Country (2015-2020)
Table 34. Latin America Vitamin K Antagonists (VKA) Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Vitamin K Antagonists (VKA) Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Vitamin K Antagonists (VKA) Sales by Country (2015-2020) (K MT)
Table 37. Middle East and Africa Vitamin K Antagonists (VKA) Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Vitamin K Antagonists (VKA) Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Vitamin K Antagonists (VKA) Revenue Market Share by Country (2015-2020)
Table 40. Global Vitamin K Antagonists (VKA) Sales (K MT) by Type (2015-2020)
Table 41. Global Vitamin K Antagonists (VKA) Sales Share by Type (2015-2020)
Table 42. Global Vitamin K Antagonists (VKA) Revenue (Million US$) by Type (2015-2020)
Table 43. Global Vitamin K Antagonists (VKA) Revenue Share by Type (2015-2020)
Table 44. Global Vitamin K Antagonists (VKA) Price (USD/MT) by Type (2015-2020)
Table 45. Global Vitamin K Antagonists (VKA) Sales (K MT) by Application (2015-2020)
Table 46. Global Vitamin K Antagonists (VKA) Sales Market Share by Application (2015-2020)
Table 47. Global Vitamin K Antagonists (VKA) Sales Growth Rate by Application (2015-2020)
Table 48. Sanofi Vitamin K Antagonists (VKA) Corporation Information
Table 49. Sanofi Description and Business Overview
Table 50. Sanofi Vitamin K Antagonists (VKA) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 51. Sanofi Main Product
Table 52. Sanofi Recent Development
Table 53. Bristol-Myers Squibb Vitamin K Antagonists (VKA) Corporation Information
Table 54. Bristol-Myers Squibb Corporation Information
Table 55. Bristol-Myers Squibb Vitamin K Antagonists (VKA) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 56. Bristol-Myers Squibb Main Product
Table 57. Bristol-Myers Squibb Recent Development
Table 58. Bayer Vitamin K Antagonists (VKA) Corporation Information
Table 59. Bayer Corporation Information
Table 60. Bayer Vitamin K Antagonists (VKA) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 61. Bayer Main Product
Table 62. Bayer Recent Development
Table 63. Johnson & Johnson Vitamin K Antagonists (VKA) Corporation Information
Table 64. Johnson & Johnson Corporation Information
Table 65. Johnson & Johnson Vitamin K Antagonists (VKA) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 66. Johnson & Johnson Main Product
Table 67. Johnson & Johnson Recent Development
Table 68. Genentech (Roche) Vitamin K Antagonists (VKA) Corporation Information
Table 69. Genentech (Roche) Corporation Information
Table 70. Genentech (Roche) Vitamin K Antagonists (VKA) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 71. Genentech (Roche) Main Product
Table 72. Genentech (Roche) Recent Development
Table 73. Boehringer Ingelheim Vitamin K Antagonists (VKA) Corporation Information
Table 74. Boehringer Ingelheim Corporation Information
Table 75. Boehringer Ingelheim Vitamin K Antagonists (VKA) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 76. Boehringer Ingelheim Main Product
Table 77. Boehringer Ingelheim Recent Development
Table 78. Lilly Vitamin K Antagonists (VKA) Corporation Information
Table 79. Lilly Corporation Information
Table 80. Lilly Vitamin K Antagonists (VKA) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 81. Lilly Main Product
Table 82. Lilly Recent Development
Table 83. Daiichi Sankyo Vitamin K Antagonists (VKA) Corporation Information
Table 84. Daiichi Sankyo Corporation Information
Table 85. Daiichi Sankyo Vitamin K Antagonists (VKA) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 86. Daiichi Sankyo Main Product
Table 87. Daiichi Sankyo Recent Development
Table 88. Otsuka Vitamin K Antagonists (VKA) Corporation Information
Table 89. Otsuka Corporation Information
Table 90. Otsuka Vitamin K Antagonists (VKA) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 91. Otsuka Main Product
Table 92. Otsuka Recent Development
Table 93. AstraZeneca Vitamin K Antagonists (VKA) Corporation Information
Table 94. AstraZeneca Corporation Information
Table 95. AstraZeneca Vitamin K Antagonists (VKA) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 96. AstraZeneca Main Product
Table 97. AstraZeneca Recent Development
Table 98. Pfizer Vitamin K Antagonists (VKA) Corporation Information
Table 99. Pfizer Corporation Information
Table 100. Pfizer Vitamin K Antagonists (VKA) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 101. Pfizer Main Product
Table 102. Pfizer Recent Development
Table 103. Aspen Vitamin K Antagonists (VKA) Corporation Information
Table 104. Aspen Corporation Information
Table 105. Aspen Vitamin K Antagonists (VKA) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 106. Aspen Main Product
Table 107. Aspen Recent Development
Table 108. The Medicines Company Vitamin K Antagonists (VKA) Corporation Information
Table 109. The Medicines Company Corporation Information
Table 110. The Medicines Company Vitamin K Antagonists (VKA) Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 111. The Medicines Company Main Product
Table 112. The Medicines Company Recent Development
Table 113. Sales Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. Vitamin K Antagonists (VKA) Distributors List
Table 116. Vitamin K Antagonists (VKA) Customers List
Table 117. Market Key Trends
Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 119. Key Challenges
Table 120. Global Vitamin K Antagonists (VKA) Sales (K MT) Forecast by Type (2021-2026)
Table 121. Global Vitamin K Antagonists (VKA) Sales Market Share Forecast by Type (2021-2026)
Table 122. Global Vitamin K Antagonists (VKA) Revenue (Million US$) Forecast by Type (2021-2026)
Table 123. Global Vitamin K Antagonists (VKA) Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 124. Global Vitamin K Antagonists (VKA) Sales (K MT) Forecast by Application (2021-2026)
Table 125. Global Vitamin K Antagonists (VKA) Revenue (Million US$) Forecast by Application (2021-2026)
Table 126. Global Vitamin K Antagonists (VKA) Sales (K MT) Forecast by Region (2021-2026)
Table 127. Global Vitamin K Antagonists (VKA) Sales Market Share Forecast by Region (2021-2026)
Table 128. Global Vitamin K Antagonists (VKA) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Global Vitamin K Antagonists (VKA) Revenue Market Share Forecast by Region (2021-2026)
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Vitamin K Antagonists (VKA)
Figure 2. Global Vitamin K Antagonists (VKA) Sales Market Share by Type: 2020 VS 2026
Figure 3. Oral Vitamin K Antagonists Product Picture
Figure 4. Injection Vitamin K Antagonists Product Picture
Figure 5. Global Vitamin K Antagonists (VKA) Consumption Market Share by Application: 2020 VS 2026
Figure 6. VTE
Figure 7. ACS/MI
Figure 8. AF
Figure 9. Others
Figure 10. Global Vitamin K Antagonists (VKA) Market Size 2015-2026 (US$ Million)
Figure 11. Global Vitamin K Antagonists (VKA) Sales Capacity (K MT) (2015-2026)
Figure 12. Global Vitamin K Antagonists (VKA) Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Vitamin K Antagonists (VKA) Sales Share by Manufacturers in 2020
Figure 14. Global Vitamin K Antagonists (VKA) Revenue Share by Manufacturers in 2019
Figure 15. The Global 5 and 10 Largest Players: Market Share by Vitamin K Antagonists (VKA) Revenue in 2019
Figure 16. Vitamin K Antagonists (VKA) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Vitamin K Antagonists (VKA) Sales Market Share by Region (2015-2020)
Figure 18. Global Vitamin K Antagonists (VKA) Sales Market Share by Region in 2019
Figure 19. Global Vitamin K Antagonists (VKA) Revenue Market Share by Region (2015-2020)
Figure 20. Global Vitamin K Antagonists (VKA) Revenue Market Share by Region in 2019
Figure 21. North America Vitamin K Antagonists (VKA) Sales Market Share by Country in 2019
Figure 22. North America Vitamin K Antagonists (VKA) Revenue Market Share by Country in 2019
Figure 23. U.S. Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 24. U.S. Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Canada Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 26. Canada Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Europe Vitamin K Antagonists (VKA) Sales Market Share by Country in 2019
Figure 28. Europe Vitamin K Antagonists (VKA) Revenue Market Share by Country in 2019
Figure 29. Germany Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 30. Germany Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. France Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 32. France Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. U.K. Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.K. Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Italy Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 36. Italy Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Russia Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 38. Russia Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Asia Pacific Vitamin K Antagonists (VKA) Sales Market Share by Region in 2019
Figure 40. Asia Pacific Vitamin K Antagonists (VKA) Revenue Market Share by Region in 2019
Figure 41. China Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 42. China Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Japan Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 44. Japan Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. South Korea Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 46. South Korea Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. India Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 48. India Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Australia Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 50. Australia Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Taiwan Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 52. Taiwan Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Indonesia Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 54. Indonesia Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Thailand Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 56. Thailand Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Malaysia Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 58. Malaysia Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Philippines Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 60. Philippines Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Vietnam Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 62. Vietnam Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Latin America Vitamin K Antagonists (VKA) Sales Market Share by Country in 2019
Figure 64. Latin America Vitamin K Antagonists (VKA) Revenue Market Share by Country in 2019
Figure 65. Mexico Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 66. Mexico Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Brazil Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 68. Brazil Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Argentina Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 70. Argentina Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Middle East and Africa Vitamin K Antagonists (VKA) Sales Market Share by Country in 2019
Figure 72. Middle East and Africa Vitamin K Antagonists (VKA) Revenue Market Share by Country in 2019
Figure 73. Turkey Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 74. Turkey Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Saudi Arabia Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 76. Saudi Arabia Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. U.A.E Vitamin K Antagonists (VKA) Sales Growth Rate (2015-2020) (K MT)
Figure 78. U.A.E Vitamin K Antagonists (VKA) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Sales Market Share of Vitamin K Antagonists (VKA) by Type (2015-2020)
Figure 80. Sales Market Share of Vitamin K Antagonists (VKA) by Type in 2019
Figure 81. Revenue Share of Vitamin K Antagonists (VKA) by Type (2015-2020)
Figure 82. Revenue Market Share of Vitamin K Antagonists (VKA) by Type in 2019
Figure 83. Global Vitamin K Antagonists (VKA) Sales Growth by Type (2015-2020) (K MT)
Figure 84. Global Vitamin K Antagonists (VKA) Sales Market Share by Application (2015-2020)
Figure 85. Global Vitamin K Antagonists (VKA) Sales Market Share by Application in 2019
Figure 86. Global Revenue Share of Vitamin K Antagonists (VKA) by Application (2015-2020)
Figure 87. Global Revenue Share of Vitamin K Antagonists (VKA) by Application in 2020
Figure 88. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Genentech (Roche) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Otsuka Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Aspen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. The Medicines Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Price Trend of Key Raw Materials
Figure 102. Manufacturing Cost Structure of Vitamin K Antagonists (VKA)
Figure 103. Manufacturing Process Analysis of Vitamin K Antagonists (VKA)
Figure 104. Vitamin K Antagonists (VKA) Industrial Chain Analysis
Figure 105. Channels of Distribution
Figure 106. Distributors Profiles
Figure 107. Porter's Five Forces Analysis
Figure 108. North America Vitamin K Antagonists (VKA) Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 109. North America Vitamin K Antagonists (VKA) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Europe Vitamin K Antagonists (VKA) Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 111. Europe Vitamin K Antagonists (VKA) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Latin America Vitamin K Antagonists (VKA) Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 113. Latin America Vitamin K Antagonists (VKA) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Middle East and Africa Vitamin K Antagonists (VKA) Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 115. Middle East and Africa Vitamin K Antagonists (VKA) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 116. Asia Pacific Vitamin K Antagonists (VKA) Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 117. Asia Pacific Vitamin K Antagonists (VKA) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 118. Bottom-up and Top-down Approaches for This Report
Figure 119. Data Triangulation
Figure 120. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs